HTHussein Hassan Twabi

Hussein Hassan Twabi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hussein Hassan Twabi has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Marriott Nliwasa

    Affiliations Helse Nord Tuberculosis Initiative, Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa

    10 shared publications
  • Elizabeth L. Corbett

    Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

    4 shared publications
  • Peter MacPherson

    School of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom

    4 shared publications
  • Robina Semphere

    Affiliations Helse Nord Tuberculosis Initiative, Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi, School of Health and Wellbeing, University of Glasgow, Scotland, United Kingdom

    4 shared publications
  • Chisomo Msefula

    Affiliation Kamuzu University of Health Sciences, Blantyre, Malawi

    3 shared publications
  • Chisomo Msefula

    Pathology Department, Kamuzu University of Health Sciences, Blantyre 312200, Malawi

    3 shared publications

Latest Publications

  • Open Access

    Optimizing peer-led health interventions: A social network analysis approach for identifying influential fishermen in Malawi

    by Madalo Mukoka, Alison Price, Marriott Nliwasa, Owen Mhango, Mphatso Mwapasa, Moses K. Kumwenda, Hussein H. Twabi, Robina Semphere, Takondwa C. Msosa, Chisomo Msefula, et al.

    Social network interventions (SNIs) can leverage influential individuals within personal networks to amplify health behavior adoption and intervention diffusion. While SNIs are potentially effective in enhancing uptake of HIV prevention and other interventions, identifying optimal peer leaders remains challenging. This study assessed how social network-based approaches can improve peer leader identification compared to non-structural approaches (i.e., those that do not use network data for promoter selection). Between 8 th October 2024 and 31 st March 2025, we mapped the social connections among fishermen in two communities in Mangochi, Malawi. The communities had previously participated in a cluster-randomized trial (FISH), which aimed to create demand among fishermen for HIV and schistosomiasis services via peer-nominated leaders. Using Network Canvas and a photographic census, we conducted a network survey, capturing ties, support roles and interaction frequency. Whole-network maps were constructed, centrality measures and the key player problem positive (KPP-POS) algorithm were applied to identify the highest-ranking individuals as potential promoters. We compared the reach (i.e., proportion of nodes within two steps of a promoter) of peer-nominated leaders selected by FISH to these sociometric methods . We recruited 370 of 397 eligible fishermen (mean age 34.8years [SD 13.11]). Both communities exhibited sparse, low-reciprocity networks with long path lengths. One network had two dense cores, while the other featured a single core. There was no evidence of assortative mixing by education, age or village of residence. FISH trial peer leaders were not consistently central in the constructed maps. The KPP-POS algorithm identified alternative, more dispersed nodes, achieving the highest reach (66% in F001; 75% in F024) versus in-degree (58%, 67%), closeness (58%, 68%), betweenness (58%, 69%) and eigenvector (60%, 68%) promoter sets. Our findings highlight that strategically identified promoters can achieve good reach within social networks, crucial for effective public health programming in complex settings like fishing communities.

  • Open Access

    Patterns and predictors of contraceptive use among post-caesarean women in Sierra Leone: insights from a five-year longitudinal study

    by Maranatha Kasonde Banda, Hussein H Twabi, Alex J. van Duinen, Marriott Nliwasa, Michael Kamara, Maria Odland

    Caesarean deliveries and short birth intervals predispose to adverse maternal outcomes. Family planning lowers this risk by reducing unplanned pregnancies. This study assessed the uptake and influencing factors of contraceptive use among women at one- and five-years post-caesarean delivery in Sierra Leone. We performed a secondary analysis of data from a multicentre, prospective observational study involving 1,274 women who underwent caesarean delivery in nine hospitals across Sierra Leone between October 2016 and May 2017. The primary outcome was the use of a modern contraceptive method within five years post-delivery. Multivariable logistic regression analyses were used to identify factors associated with contraceptive uptake. Overall contraceptive use at five years was 48.5%. The commonest method used at year one was the intrauterine contraceptive device, but this declined significantly from 40.3% to 0.8% by year five ( p < 0.001). Attending more than two antenatal care visits [aOR 1.96; 95% CI (1.19, 3.23)] and offering a contraceptive method before discharge [aOR 2.44; 95% CI (1.05, 6.40)] were associated with a higher likelihood of modern contraceptive uptake, while delivery at a tertiary/regional facility was associated with a lower likelihood [aOR 0.53; 95% CI (0.34, 0.83)]. Increased contact with the health system was associated with a higher uptake of modern contraceptive methods among post-caesarean women. Strengthening provider–client interaction and integrating contraceptive counselling into routine antenatal and postnatal care could improve contraceptive use and address the unmet need for family planning.

  • Open Access

    Towards TB elimination in Malawi: a 5-year analysis of key indicators for TB control using surveillance data

    by H.H. Twabi, T.C. Msosa, M. Mukoka, I. Mwaluka, B. Girma, T. Sikwese, J. Mpunga, T. Mwenyenkulu, D. Chimatiro, K. Mbendera, et al.

    SUMMARY: BACKGROUND: Malawi’s TB Control Programme emphasises data-driven approaches for monitoring TB control efforts, but programmatic indicators have never been systematically evaluated. This study evaluates the performance of Malawi’s TB Control Programme, providing insights into national trends, geographical distributions, and programmatic gaps in TB care. METHODS: Aggregate TB data collected through Malawi’s District Health Information System from 2018 to 2022 were analysed cross-sectionally. We analysed trends in TB incidence and case notification rates (CNRs), calculated performance indicators, and assessed district-level variations using time-series plots and statistical comparisons. Population estimates were derived from the 2018 census and adjusted for annual growth. FINDINGS: Malawi reported 18,025 new persons with TB in 2022. From 2005 to 2018, TB incidence and CNRs declined by 68.6% and 54.5%, respectively. The highest CNRs were recorded among men aged 35–64 years. Treatment success rates improved overall, reaching 89.2% in 2022, though disparities persisted for HIV-positive patients and those treated at tertiary facilities. CONCLUSION: Challenges remain in Malawi’s TB control efforts, particularly in addressing case detection gaps in high-burden districts and improving outcomes for vulnerable populations. Strengthening active case finding, enhancing diagnostic capacity, and addressing socio-economic determinants of health are essential for sustaining progress and achieving END-TB Strategy goals.


  • Open Access

    Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta‐analysis

    by Hussein H. Twabi, Akitoshi Ueno, Josephine Ives, Ross Murtagh, Madalo Mukoka, Seyed Alireza Mortazavi, David S. Lawrence, Augustine T. Choko, Robina Semphere, Kelvin Balakasi, et al.

    Introduction: People with advanced HIV disease face high risks of severe illness and death. CD4 testing enables timely diagnosis and appropriate care, yet access remains limited in many settings. This review investigated the diagnostic accuracy of the WHO clinical staging for identifying advanced HIV disease. Methods: We conducted a systematic review and meta‐analysis of studies published between 1 January 1998 and 1 May 2024 that assessed both WHO clinical staging and CD4 counts in people living with HIV aged 5 years and older (PROSPERO: CRD42024558372). We pooled sensitivity and specificity estimates of WHO Stage 3/4 for detecting advanced HIV disease (CD4 p < 0.001). In a population of 100,000 people living with HIV with 30% advanced HIV disease prevalence, WHO staging would miss 11,700 true advanced HIV disease cases and misclassify 19,600. Conclusions: WHO clinical staging alone shows low accuracy for detecting advanced HIV disease, risking both missed diagnoses and overtreatment. CD4 testing remains essential for accurately identifying and managing advanced HIV disease.


  • Open Access

    Acceptability of self-sampling for high-risk HPV DNA testing for primary cervical cancer screening among women in Thyolo, Malawi: A qualitative study

    by Hussein H. Twabi, Wakumanya Sibande, Owen Mhango, Takondwa Charles Msosa, Chikumbutso Chipandwe, Madalo Mukoka, Moses Kumwenda, Vanitha Sivalingam, Dennis Solomon, Chisomo Msefula, et al.

    Despite the roll-out of cervical cancer screening within routine health facilities, uptake of cervical cancer screening in Malawi remains low due to factors such as privacy concerns, stigma, and distance to health facility. Self-sampling for human papillomavirus (HPV) testing offers a viable alternative to provider-delivered sampling, resolving issues with accessibility and privacy related barriers. However, there is limited understanding of the acceptability of self-sampling among women in low-income settings. We aimed to assess women’s perceptions, experiences, and acceptability of self-sampling for HPV testing for primary cervical cancer screening. We conducted a qualitative phenomenological study among ten purposively sampled women screening for cervical cancer at a rural hospital in Malawi. Data collection instruments and the thematic analytical approach were guided by the Theoretical Framework of Acceptability. Key constructs that were central to this analysis included affective attitude, burden, self-efficacy, intervention coherence, and perceived effectiveness. Self-sampling emerged as a culturally and socially acceptable diagnostic practice by the women, mediated by emic values of privacy, bodily autonomy, and convenience. Women valued the ability to autonomously collect samples, which allowed them to circumvent discomfort and perceived invasiveness linked to speculum use, especially by male clinicians. Sociocultural barriers such as limited literacy levels, poor access to transport, and a lack of spousal approval restricted broader acceptability. Facilitators of acceptability included comprehension of the intervention, confidence in the self-sampling process, and the potential of the intervention to increase screening uptake, reduce cervical cancer screening-related stigma and reduce healthcare worker burden. Self-sampling for cervical cancer screening is an acceptable and promising alternative for improving the uptake of screening among women in Malawi and similar low-income countries. Scale-up of this approach will require addressing socio-cultural barriers through optimising instructional materials, engaging male partners, and leveraging community health workers for scaled community implementation via task-sharing.


  • Open Access

    Prevalence of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae in Wastewater Effluent in Blantyre, Malawi

    by Edna Ibrahim, Charity Mkwanda, Edward Masoambeta, Luigia Scudeller, Tomislav Kostyanev, Hussein H. Twabi, Yohane K. Diness, Jobiba Chinkhumba, Janelisa Musaya, Rajhab S. Mkakosya, et al.

    Background/Objectives: Wastewater treatment plants (WWTPs) serve as a sink for both antimicrobial residues and bacteria carrying resistant genes, which are later disseminated into the environment, facilitating the spread of antimicrobial resistance. This study investigated the presence of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (Ec), Klebsiella pneumoniae (Kp), and Enterobacter cloacae (Enc) in effluent from WWTP in Blantyre, Malawi, to generate evidence and provide baseline information for interventions. Methods: Selective chromogenic agar was used to identify ESBL-producing bacteria. Results: A total of 288 samples were collected between April 2023 and March 2024, and 97.6% (281/288) yielded one or more presumptive ESBL isolates. Bacterial growth was confirmed as 48.9% Ec (255/522), 33.0% Kp (172/522), and 10.0% Enc (52/522). Antibiotic susceptibility testing showed the highest resistance to ceftriaxone (Ec, 100.0%; Kp, 98.3%; Enc, 100.0%) and the lowest resistance to meropenem (Ec, 6.3%, Kp, 1.2%; Enc, 3.8%) among the antibiotics that were tested. Multiple antibiotic resistance phenotypes were observed in 73.1% of the isolates, with the most prevalent phenotype being amoxicillin + clavulanate/cotrimoxazole/doxycycline/ciprofloxacin/gentamicin/azithromycin/ceftriaxone (55, 15.7%). Conclusions: The study demonstrated ongoing environmental contamination with antibiotic-resistant bacteria from sewage effluent. Therefore, the functionality of WWTPs should be improved to minimize the release of these organisms into the environment.


  • Open Access

    The key design features and effectiveness of social network interventions for HIV testing and linkage services in low‐ and middle‐income countries: a systematic review and meta‐analysis

    by Madalo Mukoka, Takondwa C. Msosa, Hussein H. Twabi, Robina Semphere, Marriott Nliwasa, Guy Harling, Alison Price, Katherine Fielding, Augustine T. Choko

    Introduction: HIV remains a global health challenge with a reported 39 million people living with HIV (PLHIV) in 2022. Sub‐Saharan Africa, Asia and the Pacific are home to 82% of PLHIV, where limited access to healthcare resources underscores the urgency of innovative strategies to combat the epidemic effectively. Social network interventions (SNIs) hold promise for improving HIV testing and linkage services by engaging populations at greatest risk. This review evaluates the key design features and effectiveness of SNIs for HIV testing and linkage in low‐ and middle‐income countries (LMICs).Methods: We searched four databases (Medline, Embase, Global Health, Web of Science) for the period from 1st January 2003 until 16th June 2023. A combination of the terms “Social Network,” “HIV,” “testing” and “linkage” with an LMIC filter was used. We included interventional study designs that compared an SNI for HIV testing and/or linkage to care against non‐network comparator approaches. Narrative synthesis and random effects meta‐analyses were conducted to synthesize the results.Results: Of the 6763 records, 13 studies met the inclusion criteria; eight were randomized controlled trials, and five were non‐randomized designs. Nine studies engaged key populations. The most common strategy involved recruiting and training seeds, who then delivered HIV services to network members. The use of networks varied significantly across the papers. The network approaches used were induction (n = 11), alteration (n = 1) and a combination of individual and segmentation approaches (n = 1). The pooled estimates showed that SNIs had a modest effect on the uptake of HIV testing RR 1.12 [95% CI 1.08−1.17) but the directionality of effect for the proportion newly diagnosed positive (RR 0.88 [95% CI 0.74−1.04]) and linkage to care (RR 0.98 [95% CI 0.86−1.08]) was towards the null.Discussion: SNIs improved the uptake of HIV testing and exhibit important variability in their design.Conclusions: There is a need for more studies designed to capture the complex relational dynamics of network interventions and to provide strong evidence on their isolated effects. Additionally, it is necessary to expand the use of network approaches to other priority populations.PROSPERO Number: CRD42023434770


  • Open Access

    Prevalence of Extended Spectrum β-Lactamase-Producing Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae in Wastewater Effluent in Blantyre, Malawi

    by Edna Ibrahim, Charity Trinity Mkwanda, Edward Masoambeta, Luigia Scudeller, Tomislav Kostyanev, Hussein Hassan Twabi, Yohane K. Diness, Watipaso Kasambala, Jobiba Chinkhumba, Janelisa Musaya, et al.

    Background/Objectives: Wastewater treatment plants (WWTP) serve as a sink for both antimicrobial residues and bacteria carrying resistant genes which are later disseminated into the environment, facilitating the spread of antimicrobial resistance. This study investigated the presence of extended spectrum beta-lactamase (ESBL) producing Escherichia coli (Ec), Klebsiella pneumoniae (Kp) and Enterobacter cloacae (Enc) in effluent from WWTP in Blantyre, Malawi, to generate evidence and provide baseline information for interventions. Methods: Selective chromogenic agar was used to identify ESBL-producing bacteria. Results: A total of 288 samples were collected between April, 2023 and March, 2024 and 97.6% (281/288) yielded one or more presumptive ESBL isolates. Bacterial growth was confirmed as 48.9% Ec (255/522), 33.0% Kp (172/522) and 10.0% Enc (52/522). Antibiotic susceptibility testing showed higher resistance to ceftriaxone (Ec, 100.0%; Kp, 98.3%; Enc, 100.0%) and lower resistance to meropenem (Ec, 6.3%, Kp, 1.2%; Enc, 3.8%) among the antibiotics that were tested. Multiple antibiotic resistance phenotypes were observed in 73.1% of the isolates with the most prevalent phenotype as AUG-SXT-DXT-CIP-GM-ATH-CRO (55, 15.7%). Conclusions: The study demonstrated ongoing environmental contamination with antibiotic resistant bacteria from sewage effluent. Therefore, the functionality of WWTP should be improved to minimize the release of these organisms into the environment.


  • Open Access

    Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data

    by Hussein Hassan Twabi, Takondwa Charles Msosa, Samuel James Meja, Madalo Mukoka, Robina Semphere, Geoffrey Chipungu, David Lissauer, Maria Lisa Odland, Jenny Tudor, Chisomo Msefula, et al.

    Background: Malawi has one of the highest incidence and mortality rates of cervical cancer in the world. Despite a national strategic plan and the roll-out of VIA and screen-and-treat services, cervical cancer screening coverage in Malawi remains far below the national target.Using a nationally representative sample of women enumerated in the Malawi Population-based Impact Assessment (MPHIA) survey we estimated the prevalence and spatial distribution of self-reported cervical cancer screening as a proxy for uptake in Malawi. Methods: MPHIA was a nationally representative household survey in Malawi, targeting adults aged 15 and above, that employed a cross-sectional, two-stage, cluster design. The primary aim of MPHIA was to assess the regional prevalence of viral load suppression and the progress towards achieving the UNAIDS 95-95-95 goals among adults aged 15 and above. The survey was carried out between January 2020 and April 2021. Prevalence of self-reported cervical cancer screening by different characteristics was estimated accounting for the survey design using the Taylor series approach. We used univariable and multivariable logistic regression approaches to examine associations between the prevalence of cervical cancer screening and demographic characteristics. Findings: A total of 13,067 adult (15 years and older) female individuals were surveyed during the MPHIA 2020 to 2021 survey, corresponding to a weighted total of 5,604,578. The prevalence of self-reported cervical cancer screening was 16.5% (95% CI 15.5–18.0%), with women living with HIV having a higher prevalence of 37.8% (95% CI 34.8–40.9) compared to 14.0% (95% CI 13.0–15.0) in HIV negative women. The highest prevalence of screening was reported in the Southwest zone (SWZ) (24.1%, 95% CI 21.3–26.9) and in major cities of Blantyre (25.9%, 95% CI 22.9–29.0), and Lilongwe (19.6%, 95% CI 18.0–21.3). Higher self-reported screening was observed in women who resided in urban regions ((22.7%; 95% CI 21.4–24.0) versus women who resided in rural areas (15.2%; 95% CI 14.0–16.8). Cervical cancer screening was strongly associated with being HIV positive (aOR 2.83; 95% CI 2.29–3.50), ever having been pregnant (aOR 1.93; 95% CI 1.19–3.14), attaining higher education level than secondary education (aOR 2.74; 95% CI 1.67–4.52) and being in the highest wealth quintile (aOR 2.86; 95% CI 2.01–4.08). Interpretation: The coverage of cervical cancer screening in Malawi remains low and unequal by region and wealth/education class. Current screening efforts are largely being focussed on women accessing HIV services. There is need for deliberate interventions to upscale cervical cancer screening in both HIV negative women and women living with HIV.


  • Open Access

    Molecular Detection of Multi-drug resistant tuberculosis in clinical isolates from two urban centres in Malawi

    by Tionge Sikwese, Takondwa Msosa, Hussein Twabi, Samuel Dzunda, David Chaima, Billy Banda, Yusuf Kanamazina, Mirriam Nyenje, Alinune Musopole, Marriott Nliwasa, et al.

    Introduction: Suboptimal chemotherapy allows Mycobacterium tuberculosis to develop drug resistance owing to development of resistant mutants in the mycobacterial population. Early diagnosis of TB and identification of drug-resistance is of particular importance in human immunodeficiency virus (HIV)-infected individuals, as delay of therapy and subsequent development of drug-resistant TB can be devastating due to compromised immune systems. Methodology: We conducted a cross-sectional evaluation study using presumptive M. tuberculosis positive clinical isolates at two urban sites in Malawi (Blantyre and Lilongwe) to assess the presence of mutant genes on first and second line TB drugs using Line Probe Assay (LPA) and the gold standard drug susceptibility test (DST) Results: For the Lilongwe site, the incidence of MDR-TB by Line Probe Assay (LPA) was found to be 14.06% (95% CI: 8%-20%) whereas that for Rif mono-resistance was 6.25% (95% CI: 2%-10%). Contrastingly, MDR-TB by DST was 23.44% (95 CI:16% - 21%) while mono-resistance was 6.25% (95% CI:2% -10). There was a substantial agreement on the detection of MDR-TB (kappa statistic was 0.75 with 95% CI of 0.62-0.88). Blantyre site, at 9.5% confidence interval, the point estimate for MDR-TB was 0% while for INH mono-resistance TB was 3.3%. Conclusions: There is high incidence of MDR-TB among patients whose samples are sent to the Lilongwe site than previously thought. A short turnaround time to diagnosis, and the ability to simultaneously detect rifampicin and isoniazid resistance, makes LPA a reliable tool for the early detection of multidrug-resistant tuberculosis.